D
Vaxcyte, Inc. PCVX
$30.67 -$1.62-5.02% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -166.57M -140.72M -137.08M -103.12M -128.70M
Total Depreciation and Amortization 4.99M 4.87M 4.79M 4.49M 3.48M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.73M 19.09M 23.38M 8.71M 11.62M
Change in Net Operating Assets 33.69M -49.52M -2.49M 29.22M -7.79M
Cash from Operations -121.17M -166.27M -111.40M -60.71M -121.39M
Capital Expenditure -9.76M -26.75M -30.03M -38.08M -38.98M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 87.50M 150.07M -527.14M -878.94M -41.43M
Cash from Investing 77.74M 123.32M -557.17M -917.02M -80.41M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3.24M 6.05M 5.99M 1.52B 110.93M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -717.00K -5.29M -1.09M -9.34M -565.00K
Cash from Financing 2.52M 759.00K 4.91M 1.52B 110.37M
Foreign Exchange rate Adjustments 800.00K 1.17M 1.35M -5.58M -1.41M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -40.11M -41.03M -662.31M 531.73M -92.84M